Description

Diaglizid MR (Gliclazide) Tablets with Prolonged Release 60 mg. №30

Ingredients:

Each tablet contains 60 mg of gliclazide.

Mechanism of Action:

Gliclazide, the active ingredient in Diaglizid MR, is a sulfonylurea that stimulates insulin release from the pancreas, reducing blood sugar levels in patients with type 2 diabetes mellitus.

Pharmacological Properties:

Gliclazide acts by binding to specific receptors on pancreatic beta cells, leading to the closure of ATP-sensitive potassium channels and subsequent insulin release. This mechanism helps regulate glucose metabolism and control hyperglycemia.

Indications for Use:

Diaglizid MR tablets are indicated for the treatment of type 2 diabetes mellitus to achieve glycemic control and minimize the risk of diabetic complications.

Contraindications:

Avoid using Diaglizid MR if you have a known hypersensitivity to gliclazide, sulfonylureas, or if you have type 1 diabetes. Consult your healthcare provider before initiating treatment.

Side Effects:

Common side effects of Diaglizid MR may include hypoglycemia, weight gain, and gastrointestinal disturbances. Monitoring for these adverse effects is crucial during therapy.

Usage Instructions:

Take one tablet of Diaglizid MR daily, preferably with breakfast. Swallow the tablet whole with a glass of water; do not crush or chew it. Adhere to the dosing schedule recommended by your healthcare provider.

Benefits Compared to Analogues:

Studies have shown that gliclazide, particularly in prolonged-release formulations like Diaglizid MR, offers effective glycemic control with a reduced risk of hypoglycemia compared to other sulfonylureas. This feature makes it a favorable choice for managing type 2 diabetes.

Suitable Patient Groups:

Diaglizid MR is suitable for adult patients with type 2 diabetes mellitus. Dosage adjustments may be necessary for elderly individuals or those with renal impairment; consult a healthcare professional for personalized recommendations.

Storage and Shelf Life:

• Store Diaglizid MR tablets in a cool, dry place away from direct sunlight to maintain their stability.
• Check the expiration date on the packaging and do not use the tablets beyond the stated shelf life.

Packaging Description:

Diaglizid MR tablets are typically packaged in blister packs containing 30 tablets per pack. The packaging is designed to ensure product integrity and facilitate convenient dosing.